Index S&P 500
P/E 138.09
EPS (ttm) 2.31
Insider Own 5.43%
Shs Outstand 75.30M
Perf Week 3.35%
Market Cap 24.04B
Forward P/E 55.80
EPS next Y 5.71
Insider Trans -2.66%
Shs Float 71.36M
Perf Month 3.82%
Income 174.23M
PEG 7.98
EPS next Q 0.95
Inst Own 79.24%
Short Float 3.18%
Perf Quarter 23.95%
Sales 1.56B
P/S 15.38
EPS this Y 6.51%
Inst Trans 2.57%
Short Ratio 4.46
Perf Half Y 53.78%
Book/sh 21.41
P/B 14.88
EPS next Y 29.47%
ROA 5.54%
Short Interest 2.27M
Perf Year 44.22%
Cash/sh 17.53
P/C 18.18
EPS next 5Y 17.30%
ROE 12.10%
52W Range 175.37 - 329.87
Perf YTD 23.31%
Dividend Est. -
P/FCF 185.43
EPS past 5Y 35.57%
ROI 7.50%
52W High -3.43%
Beta 0.95
Dividend TTM -
Quick Ratio 2.66
Sales past 5Y 30.13%
Gross Margin 61.11%
52W Low 81.65%
ATR (14) 7.34
Dividend Ex-Date -
Current Ratio 3.00
EPS Y/Y TTM 13.27%
Oper. Margin 9.90%
RSI (14) 62.91
Volatility 1.96% 2.59%
Employees 3330
Debt/Eq 0.44
Sales Y/Y TTM 31.38%
Profit Margin 11.14%
Recom 1.38
Target Price 330.18
Option/Short Yes / Yes
LT Debt/Eq 0.44
EPS Q/Q 87.59%
Payout 0.00%
Rel Volume 0.55
Prev Close 316.75
Sales Surprise 2.73%
EPS Surprise 31.24%
Sales Q/Q 28.56%
Earnings May 06 AMC
Avg Volume 508.79K
Price 318.55
SMA20 3.63%
SMA50 3.75%
SMA200 30.56%
Trades
Volume 278,923
Change 0.57%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-10-24 Reiterated
Needham
Buy
$315 → $400
Mar-13-24 Initiated
Argus
Buy
$380
Aug-22-23 Initiated
Morgan Stanley
Equal-Weight
$230
Jul-05-23 Resumed
JP Morgan
Overweight
$236
May-11-23 Upgrade
JP Morgan
Neutral → Overweight
$236
Mar-08-23 Initiated
Goldman
Buy
$263
Mar-02-23 Downgrade
JP Morgan
Overweight → Neutral
$224
Feb-17-23 Downgrade
Raymond James
Strong Buy → Outperform
$223
Sep-15-22 Initiated
Barclays
Overweight
$147
May-23-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$120
May-10-22 Initiated
Credit Suisse
Outperform
$169
Feb-25-22 Upgrade
JP Morgan
Neutral → Overweight
$222 → $192
Dec-14-21 Resumed
JMP Securities
Mkt Outperform
$195
Nov-16-21 Upgrade
Craig Hallum
Hold → Buy
$232
May-19-21 Upgrade
Raymond James
Mkt Perform → Strong Buy
$150
Feb-12-21 Downgrade
JP Morgan
Overweight → Neutral
$129 → $179
Show Previous Ratings
Today 08:38AM
May-01-24 09:15AM
Apr-29-24 06:00PM
10:00AM
Apr-28-24 09:20AM
09:30AM
Loading…
Apr-26-24 09:30AM
Apr-25-24 09:00AM
Apr-23-24 09:30AM
Apr-22-24 06:00PM
04:01PM
Apr-19-24 12:10PM
09:45AM
Apr-16-24 06:00PM
Apr-11-24 09:30AM
09:00AM
04:49PM
Loading…
Apr-10-24 04:49PM
01:57PM
10:05AM
Apr-09-24 06:00PM
Apr-01-24 09:30AM
Mar-29-24 09:00AM
Mar-28-24 11:30AM
Mar-27-24 09:06AM
Mar-25-24 11:12PM
10:41PM
Mar-22-24 05:50PM
Mar-20-24 06:00PM
Mar-18-24 09:00AM
Mar-15-24 08:32AM
Mar-05-24 09:00AM
10:57AM
Loading…
Mar-01-24 10:57AM
Feb-29-24 02:32PM
08:55AM
Feb-28-24 04:11PM
(Investor's Business Daily) +13.76%
02:37PM
02:00PM
12:50PM
(Associated Press Finance)
11:49AM
(Investor's Business Daily)
11:49AM
(Investor's Business Daily)
10:35AM
(Thomson Reuters StreetEvents)
05:52AM
Feb-27-24 06:00PM
05:02PM
04:42PM
04:12PM
(Associated Press Finance)
04:01PM
10:16AM
Feb-20-24 05:50PM
Feb-15-24 11:41AM
09:00AM
Feb-13-24 04:01PM
Feb-12-24 05:50PM
Feb-10-24 06:39AM
Feb-05-24 05:50PM
Feb-02-24 01:40PM
(Investor's Business Daily)
Feb-01-24 09:00AM
07:00AM
Jan-30-24 05:50PM
01:18PM
Jan-26-24 08:00AM
(Investor's Business Daily)
Jan-25-24 04:05PM
Jan-24-24 05:50PM
Jan-18-24 06:00PM
Jan-17-24 09:00AM
Jan-05-24 09:00AM
Jan-03-24 06:00PM
Jan-02-24 09:30AM
Dec-26-23 10:53AM
Dec-22-23 09:30AM
Dec-21-23 01:01PM
Dec-18-23 12:17PM
Dec-16-23 07:40AM
Dec-14-23 09:40AM
09:00AM
07:04AM
Dec-12-23 07:30AM
Dec-08-23 06:42PM
Dec-07-23 11:31AM
Dec-06-23 07:05AM
Dec-03-23 06:45AM
Dec-01-23 09:30AM
Nov-30-23 09:00AM
06:30AM
Nov-28-23 04:01PM
02:30PM
12:00PM
Nov-23-23 12:20PM
Nov-22-23 07:04AM
Nov-21-23 05:30AM
Nov-20-23 11:56AM
08:35AM
Nov-17-23 06:49PM
Nov-16-23 09:00AM
Nov-13-23 02:00PM
Nov-10-23 06:58PM
Nov-08-23 07:06PM
05:55PM
10:52AM
09:34AM
(Investor's Business Daily)
12:03AM
Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Isner Joshua PRESIDENT Jan 02 '24 Sale 251.68 35,400 8,909,327 309,564 Jan 04 04:36 PM Kunins Jeffrey C CPO & CTO Dec 19 '23 Sale 256.95 2,722 699,410 226,083 Dec 20 06:48 PM Isner Joshua PRESIDENT Dec 19 '23 Sale 257.13 2,562 658,778 344,964 Dec 20 06:46 PM Isner Joshua PRESIDENT Dec 18 '23 Sale 253.46 1,956 495,775 347,526 Dec 20 06:46 PM Kunins Jeffrey C CPO & CTO Dec 18 '23 Sale 253.46 1,796 455,218 228,805 Dec 20 06:48 PM Bagley Brittany COO & CFO Dec 14 '23 Sale 250.26 5,000 1,251,291 110,752 Dec 18 04:18 PM Isner Joshua PRESIDENT Dec 05 '23 Sale 233.59 3,653 853,313 349,482 Dec 05 06:32 PM Kunins Jeffrey C CPO & CTO Dec 05 '23 Sale 230.87 2,690 621,041 230,601 Dec 05 06:35 PM Kunins Jeffrey C CPO & CTO Dec 04 '23 Sale 230.79 2,729 629,838 233,291 Dec 05 06:35 PM Isner Joshua PRESIDENT Dec 04 '23 Sale 229.60 1,400 321,445 353,135 Dec 05 06:32 PM Kunins Jeffrey C CPO & CTO Dec 01 '23 Sale 230.38 635 146,289 236,020 Dec 05 06:35 PM Isner Joshua PRESIDENT Dec 01 '23 Sale 230.38 260 59,898 356,229 Dec 05 06:32 PM Bagley Brittany COO & CFO Nov 20 '23 Sale 225.61 5,000 1,128,050 115,752 Nov 21 04:37 PM Bagley Brittany COO & CFO Nov 17 '23 Sale 223.79 5,000 1,118,960 120,752 Nov 21 04:37 PM Kunins Jeffrey C CPO & CTO Nov 10 '23 Sale 217.33 41,167 8,946,820 236,655 Nov 13 04:41 PM Isner Joshua PRESIDENT Oct 02 '23 Sale 196.37 29,699 5,831,990 356,489 Oct 04 07:11 PM Cullivan Julie A Director Sep 11 '23 Sale 214.47 515 110,452 5,367 Sep 12 08:16 PM Isner Joshua PRESIDENT Jul 03 '23 Sale 193.10 26,883 5,191,179 290,965 Jul 05 06:14 PM Kunins Jeffrey C CPO & CTO Jul 03 '23 Sale 193.12 22,900 4,422,512 241,076 Jul 05 06:11 PM Partovi Hadi Director Jun 23 '23 Buy 191.10 25,000 4,777,388 413,817 Jun 26 03:03 PM Isner Joshua CHIEF OPERATING OFFICER Jun 16 '23 Sale 203.63 1,955 398,097 317,848 Jun 16 04:34 PM Isner Joshua CHIEF OPERATING OFFICER Jun 15 '23 Sale 196.88 1,482 291,776 319,803 Jun 16 04:34 PM Cullivan Julie A Director May 30 '23 Sale 196.00 1,180 231,280 5,882 May 31 05:03 PM Partovi Hadi Director May 25 '23 Buy 190.75 10,000 1,907,471 388,817 May 25 03:16 PM Cullivan Julie A Director May 22 '23 Sale 197.58 2,013 397,729 7,062 May 23 05:38 PM Partovi Hadi Director May 17 '23 Buy 200.02 10,000 2,000,198 378,817 May 17 07:49 PM Bagley Brittany CFO & CBO May 17 '23 Buy 200.00 250 50,000 109,174 May 17 07:51 PM
Index RUT
P/E 38.30
EPS (ttm) 2.46
Insider Own 0.98%
Shs Outstand 50.45M
Perf Week 3.75%
Market Cap 4.79B
Forward P/E 21.44
EPS next Y 4.40
Insider Trans 0.00%
Shs Float 50.29M
Perf Month 11.20%
Income 126.57M
PEG 3.19
EPS next Q 0.89
Inst Own 100.98%
Short Float 4.45%
Perf Quarter 23.69%
Sales 1.27B
P/S 3.77
EPS this Y 30.66%
Inst Trans -0.61%
Short Ratio 4.59
Perf Half Y 9.27%
Book/sh 18.57
P/B 5.08
EPS next Y 11.21%
ROA 6.21%
Short Interest 2.24M
Perf Year 15.42%
Cash/sh 3.82
P/C 24.72
EPS next 5Y 12.00%
ROE 14.72%
52W Range 70.74 - 95.26
Perf YTD 10.40%
Dividend Est. -
P/FCF 37.57
EPS past 5Y 21.43%
ROI 7.03%
52W High -0.90%
Beta 0.40
Dividend TTM -
Quick Ratio 1.76
Sales past 5Y 5.50%
Gross Margin 51.78%
52W Low 33.45%
ATR (14) 2.14
Dividend Ex-Date -
Current Ratio 2.92
EPS Y/Y TTM 32.86%
Oper. Margin 15.76%
RSI (14) 76.15
Volatility 1.99% 2.37%
Employees 3034
Debt/Eq 0.92
Sales Y/Y TTM 12.48%
Profit Margin 9.97%
Recom 1.71
Target Price 105.83
Option/Short Yes / Yes
LT Debt/Eq 0.91
EPS Q/Q -5.58%
Payout 0.00%
Rel Volume 0.76
Prev Close 93.33
Sales Surprise 4.80%
EPS Surprise 10.46%
Sales Q/Q 10.14%
Earnings May 09 BMO
Avg Volume 487.44K
Price 94.40
SMA20 8.75%
SMA50 15.51%
SMA200 11.11%
Trades
Volume 368,663
Change 1.15%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-13-22 Initiated
Mizuho
Buy
$90
Jan-27-22 Downgrade
Needham
Buy → Hold
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$75 → $59
Aug-17-21 Resumed
Raymond James
Outperform
$75
Jun-17-21 Initiated
Citigroup
Buy
$75
May-14-21 Upgrade
CJS Securities
Market Perform → Market Outperform
Apr-20-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Apr-19-21 Downgrade
CJS Securities
Market Outperform → Market Perform
Feb-03-21 Upgrade
Barrington Research
Mkt Perform → Outperform
$140
Jan-21-21 Downgrade
Barrington Research
Outperform → Mkt Perform
Nov-05-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$106
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Jan-10-20 Initiated
Needham
Buy
$138
Aug-07-19 Reiterated
Barrington Research
Outperform
$116 → $139
May-14-19 Upgrade
Raymond James
Mkt Perform → Outperform
$110
May-08-19 Reiterated
Barrington Research
Outperform
$112 → $116
Aug-09-18 Reiterated
Barrington Research
Outperform
$90 → $118
Feb-07-18 Reiterated
Barrington Research
Outperform
$57 → $71
Jan-02-18 Upgrade
Morgan Stanley
Equal-Weight → Overweight
Show Previous Ratings
May-01-24 11:51AM
Apr-12-24 09:03AM
Apr-10-24 04:58PM
Apr-08-24 03:20PM
Apr-05-24 09:48AM
06:30AM
Loading…
Apr-04-24 06:30AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-11-24 09:30AM
Mar-06-24 06:54AM
Mar-05-24 06:18AM
06:00AM
Feb-27-24 12:00PM
Feb-21-24 05:57PM
05:55PM
01:26PM
Loading…
Feb-18-24 01:26PM
Feb-09-24 10:39AM
10:34AM
09:40AM
Feb-08-24 10:00PM
(Thomson Reuters StreetEvents)
09:30AM
07:10AM
06:33AM
06:10AM
(Associated Press Finance)
06:00AM
Feb-05-24 09:16AM
Feb-01-24 10:00AM
Jan-31-24 12:45PM
Jan-18-24 09:40AM
Jan-12-24 09:45AM
04:05PM
Loading…
Jan-11-24 04:05PM
Jan-03-24 01:56PM
Dec-29-23 12:34PM
Dec-25-23 09:30AM
09:30AM
Dec-18-23 09:45AM
Dec-15-23 12:45PM
Dec-12-23 06:00AM
Dec-07-23 04:05PM
Dec-05-23 09:40AM
Dec-04-23 12:09PM
Nov-30-23 09:35AM
Nov-28-23 12:45PM
Nov-27-23 12:39PM
10:46AM
Nov-23-23 09:45AM
Nov-10-23 12:45PM
Nov-06-23 09:45AM
Nov-05-23 02:30PM
Nov-03-23 10:31AM
Nov-02-23 09:30AM
07:34AM
07:00AM
06:18AM
(Associated Press Finance)
06:00AM
Nov-01-23 06:27PM
Oct-26-23 10:02AM
Oct-20-23 12:45PM
09:40AM
Oct-19-23 11:49AM
Oct-18-23 11:10AM
11:05AM
Oct-17-23 11:17AM
08:33AM
Oct-16-23 08:28AM
Oct-13-23 10:05AM
08:28AM
Oct-12-23 12:04PM
11:58AM
08:33AM
08:14AM
Oct-11-23 12:00PM
11:13AM
08:23AM
Oct-10-23 06:00AM
06:00AM
Oct-09-23 08:35AM
Oct-06-23 07:48AM
Oct-05-23 04:05PM
11:16AM
09:51AM
08:32AM
08:25AM
Oct-04-23 09:50AM
09:40AM
08:47AM
Oct-03-23 11:11AM
08:56AM
Sep-29-23 09:45AM
08:49AM
08:32AM
Sep-28-23 10:37AM
09:06AM
Sep-27-23 09:12AM
07:47AM
Sep-26-23 11:10AM
11:06AM
08:02AM
Sep-25-23 11:40AM
09:45AM
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Strong Stewart W President, Global Hospital Sep 12 '23 Sale 90.65 228 20,668 16,221 Sep 13 04:19 PM Lingamneni Anila EVP, Chief Technology Officer Sep 11 '23 Sale 90.00 2,305 207,450 14,495 Sep 13 04:20 PM Dockendorff Charles J Director Sep 05 '23 Sale 87.68 10,215 895,651 2,226 Sep 07 04:23 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Option Exercise 57.10 4,928 281,390 23,391 Jul 20 04:17 PM Llorens Josep EVP, Global Manufacturing Jul 18 '23 Sale 90.00 4,928 443,520 18,463 Jul 20 04:17 PM Simon, Christopher President & CEO Jun 29 '23 Option Exercise 28.61 196,746 5,629,887 414,113 Jun 30 04:17 PM Strong Stewart W President, Global Hospital Jun 07 '23 Option Exercise 56.93 6,893 392,419 24,040 Jun 09 04:16 PM Strong Stewart W President, Global Hospital Jun 07 '23 Sale 88.04 2,538 223,446 16,449 Jun 09 04:16 PM Lingamneni Anila EVP, Chief Technology Officer May 30 '23 Sale 83.33 2,304 191,992 16,800 Jun 01 04:19 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite